Testing for and frequency of EGFR and ALK alterations in patients with early and locally advanced non-small cell lung cancer in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315) 10. November 2023 Eberhardt WEE, Thomas M, Stuschke M, De Wit M, Seese B, Spring L, Andres-Pons A, Jaenicke M, Vahtrik O, Ludwig P, Hipper A, Hoffknecht P, von der Heyde E, Sebastian M, Gröschel A, Passlick B, Griesinger F Link First glance on outcome in routine care of patients with multiple myeloma in Germany – results from the MYRIAM registry Reiser, M., von der Heyde, E., Dechow, T., Bürkle, D., Groschek, M., Kiewe, P., Hansen, T., Langer, C., Medinger, T., Jänicke, M., Potthoff, K., Engelhardt,… Weiterlesen Systemic treatment of cholangiocellular carcinoma in Germany – Results from the prospective national intersectoral cohort study JADE Freiberg-Richter J, Uhlig J, von der Heyde E, Schröder J, Pereira PL, Hofmann WP, et al. Onco Targets Ther. 2023;46 (Suppl.5)(V309):354 Link… Weiterlesen